p53, but not p16 mutations in oral squamous cell carcinomas are associated with specific CYP1A1 and GSTM1 polymorphic genotypes and patient tobacco use

Carcinogenesis

Volumn 19, Issue 3, 1998, Pages 509-514

  Lazarus, Philip ^a   Sheikh, Sabina N ^a   Ren, Qing ^a   Schantz, Stimson P ^b   Stern, Jordan C ^c   Richie Jr , John P ^d   Park, Jong Y ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c NEW YORK EYE AND EAR INFIRMARY   (United States)

^d AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16; PROTEIN P53;

ADULT; AGED; ARTICLE; EXON; GENE MUTATION; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOUTH CARCINOMA; PREVALENCE; PRIORITY JOURNAL; SMOKING; SQUAMOUS CELL CARCINOMA; TOBACCO; TUMOR SUPPRESSOR GENE;

BENZO(A)PYRENE; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYTOCHROME P-450 CYP1A1; EXONS; GENES, P53; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MOUTH NEOPLASMS; MUTATION; NITROSAMINES; PLANTS, TOXIC; POLYMORPHISM, GENETIC; SMOKING; TOBACCO;

EID: 0031950018     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.3.509     Document Type: Article

References (33)

1. Warholm, M., Guttenburg, C., Mannervik, B. and von Bahr, C. (1981) Purification of a new glutathione S-transferase (transferase μ) from human liver having high activity with benzo[a]pyrene-4,5-oxide. Biochem. Biophys. Res. Commun., 98, 512-519.
2. Philips, D.H. (1983) Fifity years of benzo[a]pyrene. Nature, 303, 468-472.
3. Kihara, M., Kihara, M., Noda, K. and Okamoto, N. (1993) Increased risk of lung cancer in Japanese smokers with class mu glutathione S-transferase gene deficiency. Cancer Lett., 71, 151-155.
4. Nazar-Stewart, V., et al. (1993) The glutathione S-transferase μ polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res., 53, 2313-2318.
5. McWilliams, J.E., Sanderson, B.J.S., Harris, E.L., Richert-Boe, K.E. and Henner, W.D. (1995) Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidem. Biomarkers Prev., 4, 589-594.
6. Bell, D.A., Taylor, J.A., Paulson, D.F., Robertson, C.N., Mohler, J.L. and Lucier, G.W. (1993) Genetic risk and carcinogen exposure: a common inherited defect of carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl. Cancer Inst., 85, 1159-1164.
7. Cosma, G., Crofts, F., Taioli, E., Toniolo, P. and Garte, S. (1993) Relationship between genotype and function of the human CYP1A1 gene. J. Toxicol. Environ. Hlth, 40, 309-316.
8. Crofts, F., et al. (1994) Functional significance of different human CYP1A1 genotypes. Carcinogenesis, 15, 2961-2963.
9. 462: Assessment of a role of the rare allele in carcinogenesis. Cancer Res., 56, 3926-3933.
10. Hamada, G.S., et al. (1995) The heme-binding region polymorphism of cytochrome P4501A1 (CYP1A1), rather than the RsaI polymorphism of IIE1(CYPIIE1), is associated with lung cancer in Rio de Janeiro. Cancer Epid. Biomarkers Prev., 4, 63-67.
11. Nakachi, K., Imai, K., Hayashi, S. and Kawajiri, K. (1993) Polymorphisms of lung cancer in relation to cigarette dose in a Japanese population. Cancer Res., 53, 2994-2999.
12. Verbin, R.S., Bouquot, J.E., Guggenheimer, J., Barnes, L.P. and Peel, L. (1993) Cancer of the oral cavity and oropharynx. In Barnes, L.P. (ed.) Surgical Pathology of the Head and Neck, pp 333-401. M. Dekker, New York.
13. Lazarus, P., Stern, J., Zwiebel, N., Fair, A., Richie, J.P., Jr and Schantz, S. (1996) Relationship between p53 mutation incidence in oral cavity squamous cell carcinomas and patient tobacco use. Carcinogenesis, 17, 733-739.
14. Greenblatt, M.S., Bennett, W.P., Hollstein, M. and Harris, C.C. (1994) Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878.
15. Zhang, S.Y., et al. (1994) Higher frequency of alterations in the p16/ CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res., 54, 5050-5053.
16. Cairns, P., et al. (1995) Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nature Gen., 11, 210-212.
17. Reed, A.L., et al. (1996) High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res., 56, 3630-3633.
18. Olshan, A.F., et al. (1997) Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV. Oncogene, 14, 811-818.
19. Matsuda, H., et al. (1996) Alterations of p16/CDKN2, p53 and ras genes in oral squamous cell carcinomas and premalignant lesions. J. Oral Path. Med., 25, 232-238.
20. Sakata, K. (1996) Alterations of tumor suppressor genes and the H-ras oncogene in oral squamous cell carcinoma. J. Oral Path. Med., 25, 302-307.
21. Sakai, E., et al. (1992) The p53 tumor-suppressor gene and ras oncogene mutations in oral squamous-cell carcinoma. Cancer Res., 52, 867-872.
22. Brennan, J.A., et al. (1995) Association between cigarette smoking and mutations of the p53 gene in squamous cell carcinoma of the head and neck. New Engl. J. Med., 332, 712-717.
23. Denissenko, M.E. Pao, A., Tang, M.-S. and Pfeifer, G.P. (1996) Prefential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science, 274, 430-432.
24. Kawajiri, K., Eguchi, H., Nakachi, K., Sekiya, T. and Yamamoto, M. (1996) Association of CYP1A1 germ line polymorphisms with mutations of the p53 gene in lung cancer. Cancer Res., 56, 72-76.
25. Park, J.Y., et al. (1997) CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epidem. Biomarkers Prev., 6, 791-797.
26. Franco, E.L., et al. (1989) Risk factors for oral cancer in Brazil. Int. J. Cancer, 43, 992-1000.
27. Lazarus, P., et al. (1995) A low incidence of p53 mutations in premalignant lesions of the oral cavity from non-tobacco users. Int. J. Cancer, 60, 458-463.
28. Soussi, T., et al. (1994) Multifactorial analysis of p53 alterations in human cancer: a review. Int. J. Cancer, 57, 1-9.
29. Cantlay, A.M., Smith, C.A.D., Wallace, W.A., Yap, P.-L., Lamb, D. and Harrison, D.J. (1994) Heterogeneous expression and polymorphic genotype of glutathione S-transferase in human lung. Thorax, 49, 1010-1014.
30. Belinsky, S.A., et al. (1991) Role of Clara cells and type II cells in the development of pulmonary tumors in rats and mice following exposure to a tobacco-specific nitrosamine. Exp. Lung Res., 17, 263-278.
31. Oreffo, V.I., Lin, H.-W., Padmanabhan, R. and Witschi, H. (1993) K-ras and p53 point mutations in 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone-induced hamster lung tumors. Carcinogenesis, 14, 451-455.
32. Ruggeri, B., DiRado, M., Zhang, S.Y., Bauer, B., Goodrow, T. and Klein-Szanto, A.J.P. (1993) Benzo[a]pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene. Proc. Natl Acad. Sci. USA, 90, 1013-1017.
33. Berger, J. and Wynder, E. (1994) The correlation of epidemiological variables. J. Clin. Epid., 47, 941-952.